CIK 0001755237
- Non-accelerated filer
- Smaller reporting company
Korsana Biosciences, Inc.
Sign in to watch- Ticker
- KRSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 831895370
- Phone
- +1 781-516-2325
- Business address
- 203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
- Former names
- Cyclerion Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-20 | Busch Andreas Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2021-12-09 | Busch Andreas Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-11-09 | Busch Andreas Chief Innovation Officer | Purchase | +125,000 | $2.53 | $316K | 254,704 |
| 2020-11-04 | Busch Andreas Chief Innovation Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-11-22 | Busch Andreas Chief Innovation Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-11-15 | Busch Andreas Chief Innovation Officer | Purchase | +125,000 | $1.82 | $228K | 125,000 |
| 2019-04-29 | Busch Andreas Chief Innovation Officer | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 |
Page 1 of 1 · 7 trades